← Back to Clinical Trials
Recruiting NCT05940857

US National OCS Liver Perfusion (OLP) Registry

Trial Parameters

Condition Liver Transplant
Sponsor TransMedics
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2021-10-14
Completion 2031-10
Interventions
OCS Liver

Brief Summary

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

Eligibility Criteria

All liver transplant recipients.

Related Trials